YOLFTbeta
60

Beijing Tiantan Biological Products Corp Ltd

600161 · SHG · Healthcare / Biotechnology

12.01CNY-0.21 (-1.72%)

Price History

Full chart

Market Stats

Previous Close12.22
Open12.23
Day Range11.97 – 12.29
52-Week Range11.12 – 19.38
Volume18.79M
Market Cap24.90B
P/E (TTM)33.13
Forward P/E17.67
EPS0.38
Dividend Yield1.19%
Beta0.21
50-Day Avg12.40
200-Day Avg14.22

About

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Hui Chuan Yang
  • Employees5.21K
  • HeadquartersNo.B2 Shuangqiao Road, Beijing, China, 100024, China
  • Websitehttps://www.tiantanbio.com

Leadership

  • Mr. Hui Chuan YangGM & Director · b. 1969
  • Mr. Hongqing WangChief Financial Officer · b. 1982
  • Mr. Yanlin HeDeputy General Manager · b. 1968
  • Mr. Ding YuDeputy General Manager · b. 1976

Financials

Income Statement

Currency: CNY1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue100.28M76.68M75.17M105.92M137.50M137.58M155.00M199.66M244.91M290.05M343.36M413.78M530.50M682.70M1.10B1.20B1.39B1.50B1.84B1.83B1.62B2.14B2.48B2.93B3.28B3.45B4.11B4.26B5.18B6.03B6.14B
Growth (%)--23.54%-1.96%+40.90%+29.81%+0.06%+12.66%+28.81%+22.67%+18.43%+18.38%+20.51%+28.21%+28.69%+61.16%+9.27%+15.98%+7.74%+22.24%-0.54%-11.42%+32.17%+16.12%+18.03%+11.97%+4.99%+19.35%+3.63%+21.57%+16.44%+1.77%
Cost of Revenue48.60M35.52M29.52M51.32M58.92M49.00M66.02M93.22M122.43M144.42M152.03M159.69M199.78M240.32M403.21M502.61M543.59M666.77M840.08M825.44M915.15M1.03B1.21B1.56B1.66B1.75B2.16B2.17B2.55B2.74B3.56B
Gross Profit51.67M41.16M45.66M54.59M78.57M88.57M88.98M106.44M122.48M145.63M191.33M254.09M330.72M442.38M697.04M699.65M850.80M835.58M996.43M1.00B702.83M1.11B1.27B1.37B1.62B1.70B1.95B2.09B2.63B3.29B2.58B
Gross Margin51.53%53.68%60.74%51.54%57.15%64.38%57.41%53.31%50.01%50.21%55.72%61.41%62.34%64.80%63.35%58.19%61.02%55.62%54.26%54.81%43.44%51.74%51.13%46.71%49.50%49.19%47.51%49.02%50.72%54.59%42.02%
Operating Expense9.36M9.65M11.33M14.51M28.69M42.87M49.03M64.13M71.05M89.62M105.43M127.35M147.62M214.98M342.72M448.45M518.78M388.52M459.17M716.21M521.06M758.56M-270.10M500.65M577.24M590.51M708.70M656.94M822.78M734.85M813.13M
Operating Income42.32M31.51M34.33M40.08M49.88M45.70M39.95M42.31M51.43M56.01M85.90M126.74M183.10M227.40M354.32M251.21M332.02M447.06M537.26M284.90M181.78M347.85M1.54B868.36M1.05B1.10B1.24B1.43B1.80B2.56B1.77B
Operating Margin42.20%41.09%45.66%37.84%36.28%33.22%25.77%21.19%21.00%19.31%25.02%30.63%34.51%33.31%32.20%20.89%23.81%29.76%29.25%15.60%11.23%16.27%62.00%29.63%31.92%32.06%30.27%33.61%34.84%42.40%28.77%
EBITDA44.75M34.45M-8.04M52.56M62.61M60.45M58.84M66.97M84.33M90.96M119.30M168.08M240.02M412.08M451.04M374.48M478.88M536.36M672.34M509.95M489.20M661.68M940.68M980.84M1.15B1.18B1.31B1.45B1.95B2.78B2.22B
EBITDA Margin44.62%44.93%-10.70%49.63%45.54%43.94%37.96%33.54%34.43%31.36%34.75%40.62%45.24%60.36%40.99%31.15%34.34%35.70%36.61%27.92%30.24%30.94%37.88%33.46%35.03%34.29%31.92%34.07%37.72%46.04%36.16%
Net Income30.21M21.68M23.00M33.58M43.16M37.92M34.35M36.30M43.23M47.53M69.00M101.05M104.70M133.38M211.66M174.92M233.35M304.91M372.03M128.39M9.98M256.89M1.17B509.48M611.09M639.01M760.01M880.92M1.11B1.55B1.09B
Net Income Margin30.13%28.27%30.59%31.70%31.39%27.56%22.16%18.18%17.65%16.39%20.10%24.42%19.74%19.54%19.24%14.55%16.73%20.30%20.26%7.03%0.62%12.01%47.24%17.38%18.62%18.55%18.48%20.67%21.42%25.68%17.77%
R&D---------------48.23M64.13M60.05M64.89M94.36M111.88M142.55M94.30M105.36M118.68M119.87M133.21M122.01M139.95M173.31M147.66M
R&D as % of Total Revenue---------------4.01%4.60%4.00%3.53%5.17%6.91%6.67%3.80%3.59%3.62%3.48%3.24%2.86%2.70%2.87%2.41%
Interest Expense4.28M3.13M3.29M3.47M3.86M5.12M6.02M6.52M5.94M3.16M647.83K2.47M5.99M27.62M19.08M23.58M49.78M38.69M29.03M128.73M125.13M103.67M39.78M6.56M896.61K4.27M3.09M4.08M6.00M7.89M10.00M
Interest Expense % of Total Revenue4.27%4.08%4.38%3.28%2.81%3.72%3.89%3.27%2.43%1.09%0.19%0.60%1.13%4.05%1.73%1.96%3.57%2.57%1.58%7.05%7.73%4.85%1.60%0.22%0.03%0.12%0.08%0.10%0.12%0.13%0.16%

Balance Sheet

Currency: CNY1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets124.85M133.25M157.25M378.34M439.55M445.98M463.32M504.77M758.95M762.49M848.76M1.06B1.09B1.20B2.16B2.45B3.22B4.81B5.63B6.02B5.63B5.78B3.67B5.07B6.31B7.54B11.58B12.94B14.19B15.87B16.64B
Total Liabilities65.18M73.06M64.88M112.54M159.88M166.77M173.64M215.73M159.24M125.70M179.67M356.20M369.34M439.35M1.21B1.31B1.78B3.03B3.46B3.80B3.40B3.34B481.46M720.19M1.14B1.51B1.31B1.58B1.43B1.34B1.22B
Total Equity59.67M60.19M92.37M265.80M279.23M278.73M289.14M288.52M599.18M636.26M668.56M656.10M648.03M664.08M798.66M1.05B1.29B1.55B1.93B1.94B1.94B2.19B3.04B3.37B3.94B4.52B8.05B8.80B9.82B11.14B11.74B
Cash21.66M23.30M9.97M118.57M109.09M70.95M54.21M85.13M246.13M192.21M229.69M153.19M157.44M165.01M344.63M322.37M333.95M409.25M675.07M953.03M563.61M660.32M1.76B1.25B1.41B1.75B4.33B3.71B4.55B2.69B1.99B
Total Debt30.50M28.70M57.30M80.82M84.20M84.20M114.20M134.20M80.00M15.00M-130.00M140.00M220.00M480.00M880.20M1.35B1.74B2.13B2.61B2.28B2.34B200.00M230.79M400.60M800.97M508.92M403.17M24.42M44.86M187.29M
Net Debt8.84M5.40M47.33M-37.75M-24.89M13.25M59.99M49.07M-166.13M-177.21M-229.69M-23.19M-17.44M54.99M135.37M557.82M1.01B1.33B1.45B1.66B1.72B1.68B-1.56B-1.02B-1.01B-947.15M-3.82B-3.31B-4.53B-2.64B-1.80B

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow23.71M42.58M47.90M46.49M84.38M62.93M110.11M131.69M154.36M153.55M276.39M448.23M184.85M353.15M432.00M566.43M477.95M473.26M428.37M218.39M677.92M642.47M702.11M980.35M1.13B2.39B819.78M375.94M
Investing Cash Flow-55.16M-51.85M-54.05M-49.02M-34.04M-89.90M-85.60M-39.47M-159.22M-76.55M-175.59M-206.74M-521.64M-714.07M-536.90M-500.35M-461.78M-300.22M-209.33M1.52B-317.60M-565.82M-620.47M-2.18B-1.87B-1.28B-1.86B86.94M
Financing Cash Flow140.05M-210.16K-32.00M-14.21M-19.42M187.97M-78.42M-54.74M-71.65M-72.74M-93.24M-76.58M313.19M371.80M140.57M207.65M271.37M-567.52M-159.50M-582.01M-1.03B86.87M254.17M2.77B-378.20M-508.08M-370.29M-442.17M
Capital Expenditure57.61M43.34M44.04M49.09M34.83M90.02M85.89M39.78M71.50M66.40M150.31M191.17M297.54M718.67M557.87M548.37M464.16M300.57M209.39M144.87M293.90M526.23M608.91M1.13B1.35B1.08B1.07B605.53M
Free Cash Flow-33.90M-759.96K3.86M-2.60M49.56M-27.09M24.21M91.90M82.86M87.14M126.08M257.06M-112.68M-365.52M-125.87M18.06M13.80M172.68M218.98M73.52M384.01M116.24M93.20M-151.35M-228.02M1.32B-247.63M-229.59M
Dividends Paid3.37M5.09M32.00M44.21M39.41M25.14M13.42M39.74M131.65M62.80M126.69M86.77M77.79M158.43M150.05M116.57M149.95M125.65M100.04M186.38M140.14M43.56M62.72M137.32M137.32M82.39M247.17M494.34M
FCF to OCF-142.97%-1.78%8.06%-5.59%58.73%-43.05%21.99%69.79%53.68%56.75%45.62%57.35%-60.96%-103.50%-29.14%3.19%2.89%36.49%51.12%33.66%56.65%18.09%13.27%-15.44%-20.25%54.98%-30.21%-61.07%
Dividend Paid to FCF-9.95%-669.40%828.34%-1701.92%79.53%-92.82%55.42%43.24%158.88%72.07%100.48%33.76%-69.04%-43.34%-119.21%645.36%1086.94%72.76%45.68%253.52%36.49%37.47%67.30%-90.73%-60.22%6.26%-99.81%-215.32%

Earnings

Report DateOct 25, 2009Mar 17, 2010Apr 2, 2010Jul 7, 2010Oct 24, 2010Mar 14, 2011Apr 8, 2011Jul 13, 2011Oct 13, 2011Feb 29, 2012Apr 6, 2012Jul 11, 2012Oct 11, 2012Feb 27, 2013Apr 26, 2013Aug 19, 2013Oct 10, 2013Feb 26, 2014Apr 28, 2014Aug 26, 2014Oct 28, 2014Mar 21, 2015Apr 25, 2015Aug 24, 2015Oct 23, 2015Mar 2, 2016Apr 29, 2016Aug 29, 2016Oct 28, 2016Apr 26, 2017Aug 28, 2017Oct 30, 2017Apr 28, 2018Jul 19, 2018Oct 12, 2018Apr 1, 2019Aug 22, 2019Oct 24, 2019Apr 28, 2020Aug 4, 2020Oct 28, 2020Apr 26, 2021Jul 14, 2021Oct 27, 2021Jan 10, 2022Apr 25, 2022Jul 14, 2022Oct 20, 2022Apr 24, 2023Apr 25, 2024Jul 12, 2024Oct 25, 2024Jan 20, 2025Apr 25, 2025Aug 6, 2025Oct 24, 2025Mar 27, 2026Apr 29, 2026Aug 28, 2026
EPS Estimate0.050.02--0.040.03--------0.050.05--0.060.190.120.37-----0.01--0.060.07------0.13-----------0.140.180.160.150.170.200.160.240.120.14
EPS Actual-0.010.040.050.040.03-0.010.040.040.060.010.050.050.020.080.050.070.080.020.050.260.05-0.090.010.03-0.01-0.02-0.000.050.060.050.050.070.070.100.120.080.110.100.110.120.140.110.120.130.130.080.130.130.170.160.210.160.240.120.200.100.130.060.08
Surprise-120.00%100.00%---25.00%-133.33%--------0.00%40.00%---16.67%36.84%-58.33%-123.05%----96.00%---16.67%-28.57%-------23.08%-----------14.29%16.67%0.00%60.00%-29.41%0.00%-37.50%-45.83%-50.00%-42.86%
TimingAfter-hoursPre-market--After-hoursAfter-hours--------After-hoursAfter-hours--After-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap24.90B
Enterprise Value22.33B
Trailing P/E33.13
Forward P/E17.67
Price / Sales4.40
Price / Book2.04
EPS0.38
Book Value6.04
Revenue (TTM)5.65B
Gross Profit (TTM)2.19B
EBITDA1.66B
Profit Margin13.39%
Operating Margin18.72%
Return on Equity6.80%
Return on Assets4.66%
Shares Outstanding1.98B
Shares Float920.41M
Beta0.21
Dividend Yield1.19%
Dividend Rate0.15
Payout Ratio39.47%

Dividends

20231×
0.05Jul 14, 2023
20221×
0.10Jul 15, 2022
20211×
0.08Jun 30, 2021
20201×
0.05Jul 15, 2020
20191×
0.03Jun 14, 2019
20181×
0.12Jun 22, 2018
20171×
0.13Jun 19, 2017
20121×
0.03Jul 19, 2012
20111×
0.03Apr 22, 2011
20082×
0.03Oct 23, 20080.07May 9, 2008
20071×
0.04Jun 20, 2007
20063×
0.04Sep 28, 20060.58May 23, 20060.05Apr 26, 2006
20051×
0.03Apr 20, 2005
20041×
0.01Sep 28, 2004
20031×
0.02Mar 14, 2003
20022×
0.01Sep 5, 20020.02May 13, 2002
20011×
0.03May 10, 2001
20001×
0.02Jun 6, 2000

Stock Splits

  • Jul 15, 20226:5
  • Jul 15, 20206:5
  • Jun 14, 20196:5
  • Jun 22, 201813:10
  • Jun 19, 201713:10
  • May 9, 20083:2
  • Sep 28, 20043:2
  • Jun 11, 19998:5